ORIGINAL RESEARCH
Published on 04 Feb 2026
HDAC3 inhibition as a therapeutic strategy in T-cell acute lymphoblastic leukemia via the TYK2-STAT1-BCL2 signaling pathway
doi 10.3389/fimmu.2026.1752727
- 207 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Post-Translational Modifications in Tumor Immunotherapy
Post-Translational Modifications in Tumor Immunotherapy
136
Total downloads
2,658
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 28 Jan 2026
Multi-omics characterization of RNA modification enzymes identifies NAT10 as a functionally validated prognostic biomarker in hepatocellular carcinoma
doi 10.3389/fimmu.2026.1764106
- 427 views
REVIEW
Published on 15 Jan 2026
Lactylation: the malignant playbook of hepatocellular carcinoma cells and their roadmap to therapy resistance
doi 10.3389/fimmu.2025.1752404
- 884 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: